Amedisys (AMED) News Today $90.00 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Alpine Associates Management Inc. Decreases Stock Position in Amedisys, Inc. (NASDAQ:AMED)Alpine Associates Management Inc. trimmed its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 32.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 860,717 shares of the health services provider'sNovember 20 at 6:57 AM | marketbeat.comPrincipal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED)Principal Financial Group Inc. decreased its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 30.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 75,526 shares of the health services provider's stock afterNovember 20 at 3:07 AM | marketbeat.comLMR Partners LLP Reduces Stake in Amedisys, Inc. (NASDAQ:AMED)LMR Partners LLP lessened its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 31.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 263,546 shares of the health services provider's stock afteNovember 18 at 7:29 AM | marketbeat.comTruist Financial Keeps Their Hold Rating on Amedisys (AMED)November 17, 2024 | markets.businessinsider.comAmedisys, Inc. (NASDAQ:AMED) Stock Position Decreased by ING Groep NVING Groep NV lowered its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 72.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,000 shares of the health services provider's stock after selNovember 16, 2024 | marketbeat.comUnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive LandscapeNovember 14, 2024 | finance.yahoo.comAmedisys, Inc. (NASDAQ:AMED) Sees Significant Growth in Short InterestAmedisys, Inc. (NASDAQ:AMED - Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,260,000 shares, an increase of 37.8% from the October 15th total of 1,640,000 shares. Based on an average trading volume of 387,600 shares, the days-to-cover ratio is currently 5.8 days. Approximately 7.1% of the shares of the company are sold short.November 14, 2024 | marketbeat.comUnitedHealth-Amedisys merger targeted by Justice DepartmentNovember 14, 2024 | bizjournals.comAmedisys falls as DOJ sues to block $3.3B sale to UnitedHealth (update)November 14, 2024 | msn.comUS sues to block UnitedHealth's $3.3 billion purchase of AmedisysNovember 13, 2024 | msn.comJustice Department sues to block UnitedHealth Group’s $3.3 billion purchase of AmedisysNovember 13, 2024 | msn.comJuniper Networks falls as DOJ sues to block Amedisys sale to UnitedHealthNovember 13, 2024 | msn.comDOJ sues to block UnitedHealth’s $3.3B buy of home health firm AmedisysNovember 13, 2024 | finance.yahoo.comDOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant AmedisysNovember 13, 2024 | msn.comJustice Department Sues to Block UnitedHealth’s $3.3 Billion Bid for AmedisysNovember 13, 2024 | wsj.comUS sues to block UnitedHealth's $3.3 bln purchase of AmedisysNovember 12, 2024 | reuters.comUS Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reportsNovember 12, 2024 | msn.comFY2024 EPS Estimates for Amedisys Lowered by William BlairNovember 12, 2024 | americanbankingnews.comFY2024 EPS Estimates for Amedisys Reduced by William BlairAmedisys, Inc. (NASDAQ:AMED - Free Report) - Equities researchers at William Blair decreased their FY2024 earnings per share estimates for shares of Amedisys in a research note issued to investors on Thursday, November 7th. William Blair analyst M. Larew now forecasts that the health services proNovember 11, 2024 | marketbeat.comAmedisys, Inc.: Amedisys Reports Third Quarter 2024 Financial ResultsNovember 9, 2024 | finanznachrichten.deAmedisys reports Q3 adjusted EPS $1.00, consensus $1.17November 9, 2024 | markets.businessinsider.comAmedisys Inc. Reports Steady Revenue Growth Amid MergerNovember 9, 2024 | markets.businessinsider.comQ1 Earnings Estimate for Amedisys Issued By William BlairAmedisys, Inc. (NASDAQ:AMED - Free Report) - Research analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for Amedisys in a report issued on Thursday, November 7th. William Blair analyst M. Larew anticipates that the health services provider will post earnings of $1.November 8, 2024 | marketbeat.comAmedisys (NASDAQ:AMED) Releases Quarterly Earnings Results, Misses Expectations By $0.19 EPSAmedisys (NASDAQ:AMED - Get Free Report) released its quarterly earnings data on Wednesday. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.98 earnings per share.November 7, 2024 | marketbeat.comAmedisys Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comShort Interest in Amedisys, Inc. (NASDAQ:AMED) Declines By 8.4%Amedisys, Inc. (NASDAQ:AMED - Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 1,640,000 shares, a decrease of 8.4% from the September 30th total of 1,790,000 shares. Currently, 5.1% of the shares of the company are sold short. Based on an average trading volume of 361,900 shares, the days-to-cover ratio is presently 4.5 days.October 30, 2024 | marketbeat.comAmedisys (NASDAQ:AMED) Sees Unusually-High Trading Volume - What's Next?Amedisys (NASDAQ:AMED) Sees Large Volume Increase - Should You Buy?October 28, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Receives Consensus Rating of "Hold" from BrokeragesShares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have earned a consensus recommendation of "Hold" from the five brokerages that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the companOctober 26, 2024 | marketbeat.comUnitedHealth to meet with DOJ next week to try to save Amedisys deal - BloombergOctober 25, 2024 | msn.comZacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCareOctober 24, 2024 | finance.yahoo.comUpstream Rehabilitation Names CEOOctober 22, 2024 | finance.yahoo.comJim Cramer on UnitedHealthGroup Incorporation (UNH): ‘UNH Is The Only Health Insurer That Regularly Beats Earnings’October 16, 2024 | msn.comAmedisys, Inc. (NASDAQ:AMED) Short Interest UpdateAmedisys, Inc. (NASDAQ:AMED - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 1,790,000 shares, an increase of 18.5% from the September 15th total of 1,510,000 shares. Approximately 5.6% of the shares of the stock are short sold. Based on an average trading volume of 384,000 shares, the days-to-cover ratio is currently 4.7 days.October 14, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Grows Holdings in Amedisys, Inc. (NASDAQ:AMED)Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 2,159.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,200 shares of theOctober 7, 2024 | marketbeat.comSG Americas Securities LLC Grows Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)SG Americas Securities LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 413.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 196,713 shares of the health services provider's stock after pOctober 5, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Bought by Bardin Hill Management Partners LPBardin Hill Management Partners LP lifted its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 21.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,471 shares of the health serviOctober 2, 2024 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Acquired by Squarepoint Ops LLCSquarepoint Ops LLC lifted its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 72.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,947 shares of the health services provider's stock after purcSeptember 30, 2024 | marketbeat.comMurchinson Ltd. Boosts Position in Amedisys, Inc. (NASDAQ:AMED)Murchinson Ltd. boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 69.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,979 shares of the health services provider's stock after acqSeptember 29, 2024 | marketbeat.comMackenzie Financial Corp Trims Position in Amedisys, Inc. (NASDAQ:AMED)Mackenzie Financial Corp decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 1.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 745,502 shares of the health services provSeptember 28, 2024 | marketbeat.comMarshall Wace LLP Sells 23,381 Shares of Amedisys, Inc. (NASDAQ:AMED)Marshall Wace LLP lessened its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 8.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 268,122 shares of the health services provider's stock after selling 23,3September 27, 2024 | marketbeat.comAmedisys has earned the 2023 SHPBest™ Patient Satisfaction AwardsSeptember 25, 2024 | finance.yahoo.comAmedisys has earned the 2023 SHPBest™ Patient Satisfaction AwardsSeptember 25, 2024 | globenewswire.comCanada Pension Plan Investment Board Buys 30,000 Shares of Amedisys, Inc. (NASDAQ:AMED)Canada Pension Plan Investment Board boosted its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 61.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,200 shares of theSeptember 25, 2024 | marketbeat.comLaboratory (LH) Receives a Buy from JefferiesSeptember 24, 2024 | markets.businessinsider.comSkandinaviska Enskilda Banken AB publ Boosts Holdings in Amedisys, Inc. (NASDAQ:AMED)Skandinaviska Enskilda Banken AB publ increased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 43.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 26,286 shares of the health services provider's stock after purchasing aSeptember 24, 2024 | marketbeat.comGabelli Funds LLC Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED)Gabelli Funds LLC decreased its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 216,337 shares of the health services provider's stock after sellinSeptember 23, 2024 | marketbeat.comHighbridge Capital Management LLC Buys 83,200 Shares of Amedisys, Inc. (NASDAQ:AMED)Highbridge Capital Management LLC raised its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 34.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 323,200 shares of the health services prSeptember 19, 2024 | marketbeat.comOption Care Health (OPCH) Gets a Buy from JefferiesSeptember 16, 2024 | markets.businessinsider.comAlpine Associates Management Inc. Buys 11,000 Shares of Amedisys, Inc. (NASDAQ:AMED)Alpine Associates Management Inc. boosted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 0.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,280,897 shares of the health seSeptember 16, 2024 | marketbeat.comModivCare (MODV) Receives a New Rating from JefferiesSeptember 14, 2024 | markets.businessinsider.com Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! AMED Media Mentions By Week AMED Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMED News Sentiment▼0.030.46▲Average Medical News Sentiment AMED News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMED Articles This Week▼64▲AMED Articles Average Week Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CHE News Today CRVL News Today RCM News Today MD News Today AMN News Today CCRN News Today LH News Today DGX News Today DVA News Today OPCH News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMED) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedisys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
